We wish to inform you that the Board of Directors at their meeting held on 08.08.2025 had approved the Un-audited Standalone financial Results for the Quarter ended 30.06.2025
KOVAI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kovai Medical Center & Hospital reported Q1 FY26 (quarter ended 30 June 2025) standalone results with revenue from operations of ₹373.59 crore, up about 18.7% YoY from ₹314.75 crore. Total income rose to ₹379.60 crore from ₹320.24 crore. Profit before tax grew ~25.8% to ₹76.38 crore, while profit after tax increased ~25.1% YoY to ₹57.23 crore (from ₹45.75 crore). Basic and diluted EPS climbed to ₹52.30 from ₹41.81. The Healthcare segment remains the main contributor (₹343.05 crore revenue, ₹76.38 crore segment profit), with the Education segment adding ₹30.88 crore revenue. The statutory auditor VKS Aiyer & Co issued an unqualified limited review report with no qualifications or emphasis of matter.
PAT growth of just over 25% YoY modestly outpaced revenue growth, indicating healthy margin expansion and improved operating leverage—generally positive for shareholders. However, finance costs jumped ~38% YoY (₹9.17 cr vs ₹6.63 cr), reflecting higher debt servicing, which is worth monitoring despite the strong earnings print.